Start / The Journal. / A pharmaceutical executive on trumps tariff strategy

A Pharmaceutical Executive on Trump’s Tariff Strategy

18 min • 28 juli 2025

Earlier this month, President Donald Trump announced the U.S. would impose up to a 200% tariff on imported pharmaceuticals, though he would give them up to a year and a half before fully implementing the tariffs. Trump’s goal is to bring more manufacturing to the United States, but one pharmaceutical CEO, Richard Saynor of Sandoz, says there is little incentive to build in the U.S. Jessica Mendoza hosts.

Further Listening:
- Why Trump Pushed His Tariff Deadline

- Inside the Surprise U.S.-China Trade Deal

Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Senaste avsnitt

Why Coke Isn't Getting Rid of High-Fructose Corn Syrup

31 juli | 17 min

The Chinese Coffee Giant Taking on Starbucks

30 juli | 19 min

How Volkswagen's Electric Bus Lost Its Charge

29 juli | 21 min

A Pharmaceutical Executive on Trump’s Tariff Strategy

28 juli | 18 min

What Killed 'The Late Show'?

25 juli | 23 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00